ARCHIVES

First-Line Bendamustine Doubles PFS In Non-Hodgkin and Mantle Cell Lymphoma

This article is from The Cancer Letter archive.

Vol. 36 No. 2 | February 22, 2013

Download PDF Visit The Full Archive

Related Articles

Fox Chase-U.Pa. Radiation Dept. Received Contract

October 12, 1979

ASCO Draft Recommendations Define Meaningful Trial Outcomes

April 26, 2013

Clinical Nutrition Academic Award Concept Approved

October 4, 1985

Senate Confirms Elias Zerhouni For NIH Director

May 3, 2002

Cancer Rates Keep Falling, NCI’s Progress Report Says.

December 7, 2001

Race, Age Play Role In Delay Of Surgery For Breast Cancer

December 28, 2007